The Secure by Design pledge may be catching on, but reaching that goal is only going to become more difficult as attackers advance, and applications are built at a faster pace. The Cybersecurity and ...

CARLSBAD, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today ...

KINGSTON, N.Y — The New York state Office of Parks, Recreation and Historic Preservation and the Palisades Interstate Parks Commission will host a virtual meeting sharing design progress at Sojourner ...

Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025 Dosing Complete in DT-168 Phase 1 Healthy Volunteer Trial, ...